---

---

entities : Pfizer, inc.    symbols : Gild   

save search

---

Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -10.59% | O: 0.39% H: 0.82% C: -0.74%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -13.6% | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.024 -8.85% 57K |

Health Technology

| -33.33% | O: -63.33% H: 263.64% C: 127.27%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -15.83% | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.51 -6.04% -6.43% 1.4M |

Health Technology

| -11.96% | O: -0.91% H: 11.52% C: 4.94%
drug report t-cell global therapy market

---

Everest Medicines Announces Interim Results for First Half of 2023
Published: 2023-08-24 (Crawled : 01:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -30.66% | O: -0.5% H: 0.45% C: -0.86%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -13.16% | O: 0.27% H: 1.15% C: -1.19%
CALT | $17.65 -2.4% 4K |

Health Technology

| -0.84% | O: -4.72% H: 0.0% C: 0.0%
results

---

Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published: 2023-01-16 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.27% | O: -0.2% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -46.88% | O: -2.74% H: 0.43% C: -0.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -16.42% | O: 0.33% H: 0.33% C: -0.94%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -33.39% | O: 0.83% H: 0.52% C: -1.09%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -6.26% | O: -0.01% H: 0.69% C: -0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.65% | O: 1.1% H: 0.22% C: 0.02%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -22.45% | O: -0.26% H: 0.37% C: -0.74%
COCP | $1.495 -1.39% 7.6K |

Health Technology

| -29.91% | O: 0.47% H: 11.16% C: 7.91%
hepatitis global antiviral hiv therapeutics growth market

---

Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.69% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 0.14% | O: 1.08% H: 0.0% C: -0.25%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -50.48% | O: -0.08% H: 0.21% C: -0.1%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 1.62% | O: -0.01% H: 0.08% C: -0.95%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -18.37% | O: -0.04% H: 0.16% C: -0.47%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -33.01% | O: 0.04% H: 0.21% C: -0.25%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.26% | O: -0.39% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -21.53% | O: 0.08% H: 0.66% C: 0.61%
EXEL | $22.51 0.09% 0.09% 2.3M |

Health Technology

| 47.03% | O: -0.32% H: 2.91% C: 2.75%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.24% | O: -0.46% H: 0.38% C: 0.01%
global disease report therapeutics cancer market

---

HIV Clinical Trials Market Research Report by Phase, Study Design, Sponsor, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-26 (Crawled : 13:20) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M |

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| Email alert Add to watchlist
SYNH | $42.98 0.0% 7.4M |

Health Services

| Email alert Add to watchlist
ICLR | $288.32 -1.2% -1.21% 640K |

Health Technology

| Email alert Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| Email alert Add to watchlist
covid-19 trials research global report hiv impact study market

---

Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model Myriad Genetics, Inc., a leader in genetic testing and preci...
Published: 2022-12-09 (Crawled : 13:00) - biospace.com/
SXT | $69.14 1.33% 0.0% 190K |

Distribution Services

| -8.1% | O: -0.42% H: 0.97% C: -0.33%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -50.91% | O: -0.06% H: 2.11% C: -0.06%
TRIB | $1.81 -3.72% -3.87% 5.7K |

Health Technology

| 43.75% | O: -1.56% H: 1.58% C: -1.75%
REPL | $6.47 -7.17% -7.73% 870K |

Health Technology

| -70.03% | O: -0.25% H: 5.25% C: 4.17%
MYGN F | $18.515 0.03% 0.03% 490K |

Health Technology

| -4.36% | O: -0.67% H: 1.39% C: -2.69%
IMGN | $31.23 0.03% 49M |

Health Technology

| 501.93% | O: -0.19% H: 0.77% C: -0.77%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -25.23% | O: -0.23% H: 0.0% C: -1.45%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -49.85% | O: -0.05% H: 0.75% C: -0.83%
APM | $5.9 9.87% 8.98% 37K |

Health Technology

| 50.0% | O: -16.14% H: 19.24% C: 14.67%
risk breast genetic cancer study

---

Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published: 2022-08-19 (Crawled : 14:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 3.94% | O: 3.04% H: 0.12% C: -2.22%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.26% | O: -2.05% H: 0.29% C: 0.07%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -47.67% | O: 0.54% H: 1.24% C: 0.63%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -34.86% | O: 0.01% H: 2.09% C: 1.58%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 44.23% | O: -0.62% H: 0.57% C: -0.42%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 2.64% | O: -0.25% H: 1.19% C: 0.49%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 2.65% | O: 0.78% H: 0.49% C: 0.22%
study market

---

A $41.8 Billion Global Opportunity for Small Molecule Drug Discovery by 2026 - New Research from StrategyR
Published: 2022-07-04 (Crawled : 11:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| Email alert Add to watchlist
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| Email alert Add to watchlist
drug research

---

With Market Size Valued at $13.7 Billion by 2026, it`s a Healthy Outlook for the Global Angina Pectoris Drugs Market
Published: 2022-07-04 (Crawled : 09:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| Email alert Add to watchlist
market

---

Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published: 2022-04-26 (Crawled : 13:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -15.47% | O: -1.81% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 4.62% | O: 3.09% H: 0.0% C: -2.9%
UCBJY | $63.676 -4.38% 7.2K |

Manufacturing

| 9.65% | O: -0.33% H: 0.0% C: -1.56%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| -1.79% | O: -1.19% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -9.75% | O: -0.48% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -46.84% | O: 3.08% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -20.62% | O: 2.0% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 163.24% | O: 0.34% H: 1.41% C: -1.17%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -36.49% | O: -0.09% H: 1.26% C: -0.51%
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| 45.38% | O: -0.22% H: 0.43% C: -1.25%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -15.78% | O: -0.11% H: 0.0% C: 0.0%
RIGL | $1.07 1.91% 1.87% 810K |

Health Technology

| -60.38% | O: -0.38% H: 4.92% C: -4.55%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 30.54% | O: -0.72% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 6.78% | O: -0.13% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 3.49% | O: -0.03% H: 0.53% C: -1.33%
research report therapeutics market

---

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board
Published: 2022-04-21 (Crawled : 13:00) - biospace.com/
SYK | $325.43 -0.62% 0.0% 1.8M |

Health Technology

| 23.06% | O: 1.27% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -49.16% | O: -0.16% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -36.48% | O: 1.59% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 6.06% | O: 0.68% H: 0.0% C: 0.0%
HUGE | $0.6167 1.22% 29K |

Process Industries

| -42.92% | O: 0.0% H: 0.0% C: 0.0%
pharma

---

Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
AVTE M | $21.86 1.2% 1.19% 220K |

Professional, Scientific, and T...

| 78.26% | O: -8.86% H: 4.83% C: 3.51%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -46.48% | O: 1.54% H: 1.53% C: 1.41%
VYGR | $7.5 -0.66% -0.67% 520K |

Health Technology

| 150.0% | O: -3.31% H: 2.05% C: -1.37%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -5.6% | O: 0.56% H: 0.81% C: 0.62%
financial results results therapeutics

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-07-23 (Crawled : 00:00) - fda.gov
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| Email alert Add to watchlist
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| Email alert Add to watchlist
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| Email alert Add to watchlist
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| Email alert Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| Email alert Add to watchlist
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| Email alert Add to watchlist
SCYX | $1.44 2.49% 2.43% 130K |

Health Technology

| Email alert Add to watchlist
OTIC | $0.077 |

Health Technology

| Email alert Add to watchlist

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-24 (Crawled : 14:03) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -34.9% | O: 0.23% H: 0.52% C: 0.13%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 245.82% | O: 8.21% H: 1.89% C: -0.83%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -25.99% | O: 0.31% H: 1.15% C: 0.6%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 44.88% | O: 0.37% H: 1.55% C: 0.28%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -54.87% | O: 0.0% H: 10.77% C: 10.77%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -12.62% | O: 0.29% H: 0.8% C: 0.17%
OTIC | $0.077 |

Health Technology

| -96.56% | O: -0.89% H: 3.14% C: 1.35%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -78.38% | O: 0.32% H: 0.87% C: 0.26%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 0.38% | O: 0.18% H: 2.2% C: 0.61%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -73.51% | O: 0.06% H: 0.35% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 10.99% | O: 0.71% H: 1.09% C: 0.22%

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -34.5% | O: 0.18% H: 1.54% C: 1.39%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 243.52% | O: 0.25% H: 2.13% C: 1.63%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -27.34% | O: 0.21% H: 0.83% C: 0.33%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 46.0% | O: 0.5% H: 1.37% C: 0.91%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -57.18% | O: 0.24% H: 0.73% C: -4.13%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -13.9% | O: -0.32% H: 0.17% C: -0.13%
OTIC | $0.077 |

Health Technology

| -96.58% | O: 0.0% H: 3.98% C: -1.33%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -77.82% | O: 1.39% H: 0.79% C: 0.33%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 0.44% | O: 0.57% H: 0.86% C: 0.54%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -71.68% | O: 0.5% H: 4.88% C: 4.7%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 11.0% | O: 0.4% H: 0.53% C: 0.25%

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-09 (Crawled : 10:51) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -34.57% | O: 0.39% H: 2.15% C: 2.08%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 240.18% | O: 0.29% H: 2.43% C: 2.1%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -24.18% | O: 0.5% H: 2.39% C: 2.16%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 47.02% | O: 0.48% H: 1.36% C: 0.99%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -54.87% | O: 7.18% H: 4.52% C: -4.07%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -12.58% | O: 0.88% H: 0.74% C: 0.5%
OTIC | $0.077 |

Health Technology

| -96.75% | O: -0.84% H: 5.93% C: 0.42%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -78.93% | O: 0.95% H: 2.0% C: 0.25%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -0.9% | O: 0.09% H: 2.4% C: 1.6%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -73.59% | O: 0.82% H: 2.39% C: -1.11%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 11.87% | O: 0.46% H: 1.42% C: 0.67%

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-24 (Crawled : 00:00) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -36.37% | O: 0.33% H: 0.15% C: -0.67%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 275.61% | O: 0.56% H: 1.3% C: 0.01%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -27.96% | O: 0.33% H: 1.03% C: 0.03%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 42.23% | O: 0.4% H: 0.19% C: -0.58%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -49.28% | O: -1.15% H: 1.46% C: -4.66%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -15.44% | O: 0.02% H: 0.3% C: -0.3%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 77.85% | O: 0.6% H: 0.0% C: -1.82%
OTIC | $0.077 |

Health Technology

| -96.87% | O: 1.21% H: 0.0% C: -7.2%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -77.57% | O: 0.94% H: 1.4% C: 1.06%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -2.69% | O: 0.51% H: 0.2% C: -2.42%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -67.53% | O: 0.43% H: 1.44% C: -2.16%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 5.55% | O: -0.18% H: 1.17% C: -1.12%

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-18 (Crawled : 13:27) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -36.62% | O: 0.17% H: 0.41% C: -0.32%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 283.97% | O: -0.27% H: 0.69% C: -0.19%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -26.21% | O: -0.06% H: 0.58% C: 0.28%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 41.3% | O: -0.67% H: 1.54% C: 0.95%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -49.43% | O: 0.0% H: 5.46% C: 3.16%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -14.92% | O: 0.22% H: 0.1% C: -0.26%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 72.07% | O: -0.14% H: 0.0% C: -1.3%
OTIC | $0.077 |

Health Technology

| -96.73% | O: -0.84% H: 4.63% C: 1.7%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -81.23% | O: 0.06% H: 1.35% C: -0.06%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -3.14% | O: 0.49% H: 0.66% C: -0.81%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -68.71% | O: -0.76% H: 4.91% C: 0.77%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 4.97% | O: -0.12% H: 0.4% C: -0.48%

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-05-12 (Crawled : 17:43) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -35.4% | O: 0.23% H: 1.22% C: 0.63%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 285.5% | O: 0.0% H: 0.46% C: -0.8%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -24.84% | O: 0.26% H: 1.24% C: 0.16%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 43.75% | O: -0.03% H: 1.0% C: 0.1%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -48.54% | O: -2.68% H: 7.56% C: 0.05%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -12.4% | O: -0.46% H: 0.95% C: 0.12%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 79.81% | O: -0.84% H: 3.35% C: 2.04%
OTIC | $0.077 |

Health Technology

| -96.28% | O: 1.92% H: 4.25% C: 1.42%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -81.88% | O: -1.41% H: 2.86% C: -1.76%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| -0.48% | O: -0.7% H: 1.8% C: 1.05%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -62.93% | O: -1.98% H: 6.47% C: 4.96%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 5.01% | O: -0.35% H: 0.92% C: -0.23%

---

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-04-22 (Crawled : 12:34) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -35.69% | O: -0.13% H: 0.05% C: -2.13%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 293.18% | O: -0.5% H: 0.67% C: -1.55%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -27.17% | O: -0.26% H: 0.62% C: 0.26%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 49.06% | O: -0.14% H: 0.4% C: -0.54%
XERS | $1.73 -1.7% -1.73% 2M |

Health Technology

| -54.64% | O: 0.26% H: 4.37% C: -0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -13.25% | O: -0.93% H: 0.27% C: 0.17%
REGN | $896.27 0.26% 0.25% 500K |

Health Technology

| 77.93% | O: -0.21% H: 0.0% C: -2.96%
OTIC | $0.077 |

Health Technology

| -96.61% | O: 0.0% H: 3.51% C: 0.88%
OMER | $3.045 -5.14% -5.42% 390K |

Health Technology

| -82.54% | O: 0.1% H: 0.31% C: -3.03%
GILD | $66.77 0.92% 0.91% 11M |

Health Technology

| 0.16% | O: -0.46% H: 0.05% C: -1.26%
BCRX | $4.44 -1.33% -1.35% 4.7M |

Health Technology

| -61.41% | O: -0.34% H: 8.09% C: 3.7%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 2.38% | O: -0.48% H: 0.36% C: -0.97%

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---